Breaking News: Novartis Pharma Pays $3.5M to Settle False Claims Lawsuit
Novartis A.G., a massive pharmaceutical conglomerate, agreed today to pay $3.5M to the government to settle a False Claims/Qui Tam action. South Florida is awash in medicare fraud, but what makes this case unique is that the drug-maker is not accused of encouraging unnecessary treatment or prescriptions. Instead, Novartis continued to market a drug - an extended release version of nitrogylcerin - even after the FDA concluded that the drug was ineffective. Essentially, Novartis was engaged in false advertising to doctors, which in turn led to millions of dollars in prescriptions for a useless drug.
Under the Medicare Act, once the FDA concludes that a drug is not useful, Medicare will no longer reimburse for the prescription. But Novartis intentionally deceived the government by submitting false reports that mistated the drug's regulatory status. (The blog is unclear about one aspect of this case -- if the FDA changed the drug's regulatory status, then how could the federal government simultanously claim that it was mislead by the drug-maker about the drug's regulatory status?).
The whistleblower in this False Claims Act case -- known as a relator --- will receive $525,000 as a reward for reporting the false claims. This case reiterates the federal government's aggressive anti-fraud efforts. (This settlement was also reached just days after the DOJ reached a similar settlement with a Boston hospital for nearly $3M)
Does your employer have a contract with the federal government or with Florida or another state or muncipality? Is it overbilling? Are the monthly invoices inflated? Contact an experienced Qui Tam lawyer as soon as possible.